Skip to main content
. 2021 Jan 6;59(1):54–65. doi: 10.1080/13880209.2020.1866025

Figure 6.

Figure 6.

The relative activity of caspase-9 in HeLa cells after treatment with bersaldegenin-1,3,5-orthoacetate. The cells were incubated with the compound at concentrations of 0.1–5.0 µg/mL for 1–24 h. The caspase activity was estimated by luminometer and is presented in comparison to the control (0.25% DMSO). Each sample was run in triplicate. Error bars indicate standard deviations. Significant differences relative to the control are marked with an ‘*’ (p < 0.05).